##
##
||Page||
|---|---|---|
|Report ofthe Trustees|1 to|13|
|Report ofthe Independent
Auditors|14 to|17|
|Statement of Financial Activities|18||
|Balance Sheet|19||
|Cash Flow Statement|20||
|Notes to the Cash Flow Statement|21||
|Notes tothe Financial Statements|22 to|37|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||2020|2019|
|---|---|---|---|---|---|---|
|||Unrestricted|Restricted|Endowment|Total|Total|
|||fund|funds|fund|funds|funds|
||Notes||S|S|S|S|
|INCOME AND|||||||
|ENDOWMENTS
FROM|||||||
|Donations
and legacies|3|159,584|295,417||455,001|9,562,232|
|Charitable
activities|||||||
|ILDS activities||7,423|||7,423|768,260|
|Investment
income||63,321||22,464|85,785|150,764|
|Total||230,328|295,417|22,464|548,209|10,481,256|
|EXPENDITURE ON|||||||
|Raising funds||(55,897)||6,841|(49,056)|212,588|
|Charitable
activities|7||||||
|Support the operational|||||||
|costs ofthe RDTC in Moshi||(5,831)|107,803||101,972|111,295|
|IFD general
activities||(110,738)|119,263||8,525|168,599|
|Student sponsorship|||117,800||117,800|114,792|
|ILDS activities||7,401|||7p401|139,177|
|Community
Skin Health Journal||(11,571)|15,507||3,936|61,343|
|Global Psoriasis Atlas||3,894|245,739||249,633|147,738|
|World Congress ofDermatology||(40,198)|||(40,198)|145,510|
|WHO activities||17,379|||17,379||
|Total||(195,561)|606,112|6,841|417,392|1,101,042|
|Net gains on investments||525,259||42,485|567,744|545,482|
|NET|||||||
|INCOME/(EXPENDITURE)||951,148|(310,695)|58,108|698,561|9,925,696|
|Transfers between funds|17|(152,020)|207,397|(55,377)|||
|Net movement
in funds||799,128|(103,298)|2,731|698,561|9,925,696|
|RECONCILIATION
OF FUNDS|||||||
|Total funds brought forward||14,420,265|285,241|1,146,509|15,852,015|5,926,319|
|TOTAL FUNDS CARRIED|||||||
|FORWARD||15,219,393|181,943|1,149,240|16,550,576|15,852,015|
##
##
||||||2020|2019|
|---|---|---|---|---|---|---|
|||Unrestricted|Restricted|Endowment|Total|Total|
|||fund|funds|fund|funds|funds|
||Notes|S|S|S|S|S|
|FIXEDASSETS|||||||
|Tangible assets|13|6,284|||6,284|5,574|
|Investments|14|4,694,468||1,149,240|5,843,708|5,353,890|
|||4,700,752||1,149,240|5,849,992|5,359,464|
|CURRENT ASSETS|||||||
|Debtors|15|13,517|||13,517|6,373,415|
|Cash at bank and in hand||10,568,072|181,943||10,750,015|4,177,458|
||10,581,589||181,943||10,763,532|10,550,873|
|CREDITORS|||||||
|Amounts
falling due within|||||||
|one year|16|(62,948)|||(62,948)|(58,322)|
|NET CURRENT ASSETS|10,518,641||181,943||10,700,584|10,492,551|
|TOTAL ASSETS LESS|||||||
|CURRENT LIABILITIES|15,219,393||181,943|1,149,240|16,550,576|15,852,015|
|NET ASSETS|15,219,393||181,943|1,149,240|16,550,576|15,852,015|
|FUNDS|17||||||
|Unrestricted
funds|||||15,219,393|14,420,265|
|Restricted funds|||||181,943|285,241|
|Endowment
funds|||||1,149,240|1,146,509|
|TOTALFUNDS|||||16,556,576|15,652,615|
##
##
||||2020|2019|
|---|---|---|---|---|
||Notes||5|5|
|Cash flows from operating
activities|||||
|Cash generated
from operations||1|6,396,178|3,035,026|
|Net cash provided
by operating
activities|||6,396,178|3,035,026|
|Cash flows from investing
activities|||||
|Purchase oftangible fixed assets|||(2,955)||
|Purchase offixed asset investments|||(5,885,921)|(107,975)|
|Sale offixed asset investments|||5,963,847|21,922|
|Interest received|||85,785|150,764|
|Net cash provided
by investing
activities|||160,756|64,711|
|Cash flows from financing activities|||||
|Income attributable
to endowment|||22,464|(111,799)|
|Expenditure
attributable
to endowment|||(6,841)|35,061|
|Net cash provided
by/(used
in) financing||activities|15,623|(76,738)|
|Change
in cash and cash equivalents|in||||
|the reporting
period|||6,572,557|3,022,999|
|Cash and cash equivalents
at the|||||
|beginning
ofthe reporting
period|||4,177,458|1,154,459|
|Cash and cash equivalents
at the end|||||
|ofthe reporting
period|||10,750,015|4,177,458|
##
##
|RECONCILIATION
O|F NE|T INC|OME TO NET CASH FLOW FROM|OPERATI|NG ACTIVITIES||
|---|---|---|---|---|---|---|
||||||2020|2019|
||||||5|5|
|Net income for the|reporting||period (as per the Statement of||||
|Financial Activities)|||||698,561|9,925,696|
|Adjustments
for:|||||||
|Depreciation
charges|||||1,817|1,258|
|Gain on investments|||||(567,744)|(545,482)|
|Loss on disposal of|fixed|assets|||428||
|Interest received|||||(85,785)|(150,764)|
|Income attributable|to endowment||||(22,464)|111,799|
|Expenditure
attributable||to endowment|||6,841|(35,061)|
|Decrease/(increase)|in debtors||||6,359,898|(6,291,715)|
|Increase
in creditors|||||4,626|19,295|
|Net cash provided|by operations||||6,396,178|3,035,026|
|ANALYSIS OF CHANGES||IN NET FUNDS|||||
||||At|1/1/20|Cash flow|At 31/12/20|
|||||5|5|5|
|Net cash|||||||
|Cash at bank and in|hand||4,177,458||6,572,557|10,750,015|
||||4,177,458||6,572,557|10,750,015|
|Total|||4,177,458||6,572,557|10,750,015|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|4.|INVESTMENT INCOME|INVESTMENT INCOME|||||
|---|---|---|---|---|---|---|
||||||2020|2019|
||||||$|$|
||Portfolio income||||85,650|148,811|
||Bank interest||||135|1,953|
||||||85,785|150,764|
|5.|INCOME FROM CHARITABLE ACTIVITIES||||||
||||||2020|2019|
||||Activity||5|$|
||World Congress fees||ILDS activities||7,423|768,260|
|6.|RAISING FUNDS||||||
||Raising donations|and legacies|||||
||||||2020|2019|
||||||$|$|
||Support costs||||(100,501)|171,752|
||An analysis ofsupport costs is provided|||in note 8.|||
||Investment
management||costs||||
||||||2020|2019|
||||||$|5|
||Portfolio management||||51,445|40,836|
||Aggregate
amounts||||(49,056)|212,588|
##
##
##
|CHARITABLE ACTIVITIES|COSTS|||||
|---|---|---|---|---|---|
|||||Support||
||||Direct|costs (see||
||||Costs|note 8)|Tota Is|
|||||$||
|Support the operational|costs ofthe|||||
|RDTC in Moshi|||107,803|(5,831)|101,972|
|IFD general
activities|||119,263|(110,738)|8,525|
|Student sponsorship|||117,800||117,800|
|ILDS activities|||21,286|(13,885)|7,401|
|Community
Skin Health|Journal||15,507|(11,571)|3,936|
|Global Psoriasis Atlas|||245,739|3,894|249,633|
|World Congress of Dermatology|||6,303|(46,501)|(40,198)|
|WHO activities|||11,223|6,156|17,379|
||||644,924|(178,476)|466,448|
|Included
in directs costs|were the following|costs paid as|grants;|||
|Support the RDTC in Moshi||$99,969||||
|IFD General activities||$109,279||||
|Student sponsorship||$117,800||||
|ILDS Activities||$31,223||||
##
##
||||||Governance||
|---|---|---|---|---|---|---|
||||Management||Finance|costs|
||||Tota Is||||
||||$|$|$|5|
|Raising donations|and legacies||227,003|(332,093)|4,589|(100,501)|
|Support the operational||costs ofthe|||||
|RDTC in Moshi|||10,145|(16,200)|224|(5,831)|
|IFD general activities|||105,959|(219,733)|3,036|(110,738)|
|ILDS activities|||26,771|(41,226)|570|(13,885)|
|Community
Skin|I-lealth|Journal|14,229|(26,161)|361|(11,571)|
|Global Psoriasis Atlas|||43,912|(40,579)|561|3,894|
|World Congress|ofDermatology||67,165|(115,258)|1,592|(46,501)|
|WHO activities|||24,608|(18,710)|258|6,156|
||||519,792|(809,960)|11,191|(278,977)|
##
##
|Support cost|s|, inclu|ded
in t|he above, are a|s follows:||||
|---|---|---|---|---|---|---|---|---|
||||||Support||||
||||||the||||
|||||Raising|operational|||Community|
|||||donations|costs of|IF D||Skin|
|||||and|the RDTC|general|ILDS|Health|
|||||legacies|in Moshi|activities|activities|Journal|
|||||$|$|$|$|$|
|Administration||salaries||141,402|6,060|53,902|16,252|7,896|
|Social security||||13,508|567|4,372|1,570|657|
|Pensions||||6,544|319|4,329|812|515|
|Office rent and related|||||||||
|costs||||6,579|321|4,354|816|518|
|Recruitment|fees|||1,260|61|833|156|99|
|Meetings
and||travel||1,820|89|1,203|226|143|
|Website||||8,917|435|5,896|1,107|702|
|Postage and|stationery|||201|10|131|24|16|
|Branding||||18,314|894|12,116|2,272|1,442|
|Sundries||||176|9|117|27|14|
|Legal, professional|||and||||||
|accountancy||||23,326|1,138|15,428|2,894|1,837|
|Training||||3,661|179|2,421|454|288|
|President
support costs||||1,295|63|857|161|102|
|Bank charges||||1,220|59|807|151|96|
|Foreign exchange|||||||||
|variance||||(334,231)|(16,304)|(221,149)|(41,493)|(26,330)|
|Depreciation||oftangible|||||||
|fixed assets||||745|36|492|93|59|
|Loss on sale oftangible|||||||||
|fixed assets||||173|9|117|23|14|
|Auditors'
remuneration||||4,598|224|3,042|571|362|
|Board meeting costs||||(9)||(6)|(1)|(1)|
|||||(1$L501)||(11k238)||(~11 71)|
##
##
|SUPPORT CO||STS - c|ontinued||||||
|---|---|---|---|---|---|---|---|---|
||||||||2020|2019|
||||||World||||
|||||Global|Congress||||
|||||Psoriasis|of|WHO|Total|Total|
|||||Atlas|Dermatology|activities|activities|activities|
|||||$|$|$|$|$|
|Administration||salaries||34,265|38,685|14,745|313,207|247,662|
|Social security||||840|3,468|1,733|26,715|21,156|
|Pensions||||800|2,271|369|15,959|13,256|
|Office rent and related|||||||||
|cos'Is||||804|2,283|371|16,046|15,300|
|Recruitment|fees|||154|437|71|3,071|4,814|
|Meetings
and||travel||222|631|4,172|8,506|30,830|
|Website||||1,089|3,093|502|21,741|10,684|
|Postage and|stationery|||24|69|11|486|1,649|
|Branding||||2,237|6,354|1,032|44,661|8,406|
|Sundries||||22|61|10|436|2,894|
|Legal, professional|||and||||||
|accountancy||||2,850|8,093|1,313|56,879|33,629|
|Training||||447|1,271|206|8,927|7,870|
|President
support costs||||158|449|73|3,158|3,485|
|Bank charges||||149|423|69|2,974|5,244|
|Foreign exchange|||||||||
|variance||||(40,840)|(116,001)|(18,831)|(815,179)|2,368|
|Depreciation||oftangible|||||||
|fixed assets||||91|259|42|1,817|1,258|
|Loss on sale|oftangible||||||||
|fixed assets||||21|61|10|428||
|Auditors'
remuneration||||562|1,595|259|11,213|7,780|
|Board meeting costs||||(1)|(3)|(1)|(22)|148,795|
|||||3,894|(46,501)|6,156|(278,977)|567,080|
##
##
|||2020|2019|
|---|---|---|---|
|||$|$|
|Auditors'|remuneration|11,213|7,780|
|Depreciation
- owned assets||1,817|1,258|
|Deficit on|disposal offixed assets|428||
##
##
##
|||||2020|2019|
|---|---|---|---|---|---|
|||||5|$|
|Agency and subcontract|staff|||11,563|7,262|
|Wages and salaries||||301,807|240,399|
|Social security costs||||26,553|21,157|
|Employer contributions|to defined|contribution|pension schemes|15,956|13,252|
|||||355,879|282,070|
##
|12.|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|||
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Endowment|Tota I|
|||||fund|funds|fund|funds|
|||||5|5|5|5|
||INCOME AND ENDOWMENTS||FROM|||||
||Donations
and legacies|||9,129,751|432,481||9,562,232|
||Charitable
activities|||||||
||ILDS activities|||768,260|||768,260|
||Investment
income|||114,282||36,482|150,764|
||Total|||10,012,293|432,481|36,482|10,481,256|
||EXPENDITURE ON|||||||
||Raising funds|||206,886||5,702|212,588|
||Charitable
activities|||||||
||Support the operational|costs ofthe||||||
||RDTC in Moshi|||21,749|89,546||111,295|
||IFD general activities|||92,641|75,958||168,599|
||Student sponsorship||||114,792||114,792|
||ILDS activities|||139,177|||139,177|
||Community
Skin Health Journal|||22,487|38,856||61,343|
||Global Psoriasis Atlas|||55,411|92,327||147,738|
||World Congress of Dermatology|||145,510|||145,510|
||Total|||683,861|411,479|5,702|1,101,042|
||Net gains on investments|||494,022||51,460|545,482|
||NET INCOME|||9,822,454|21,002|82,240|9,925,696|
||Transfers between
funds|||(179,405)|179,405|||
||Net movement
in funds|||9,643,049|200,407|82,240|9,925,696|
||RECONCILIATION
OF FUNDS|||||||
||Total funds brought forward|||4,777,216|84,834|1,064,269|5,926,319|
||TOTIII FORDS FARRIROFORINARD|||14420 265|285 241|1 146500|15852 015|
##
|13.|TANGIBLE FIXEDASSETS||
|---|---|---|
|||Office|
|||equipment|
||COST||
||At 1January 2020|16,832|
||Additions|2,955|
||Disposals|(3,780)|
||At 31December 2020|16,007|
||DEPRECIATION||
||At 1January 2020|11,258|
||Charge for year|1,817|
||Eliminated
on disposal|(3,352)|
||At 31December 2020|9,723|
||NET BOOK VALUE||
||At 31December 2020|6,284|
||At 31December 2019|5,574|
|14.|FIXEDASSET INVESTMENTS||
|||Unlisted|
|||investments|
||MARKET VALUE||
||At 1January 2020|5,353,890|
||Additions
& reinvested|5,885,921|
||Disposals|(5,963,847)|
||Revaluations|567,744|
||At 31December 2020|5,843,708|
||NET BOOK VALUE||
||At 31December 2020|5,843,708|
||At 31December 2019|5,353,890|
##
##
##
||||||2020|2019|
|---|---|---|---|---|---|---|
||||||5|5|
|Trade debtors|||||4,415|(1,245)|
|Prepayments
and accrued||||income|9,102|6,374,660|
||||||13,517|6,373,415|
|CREDITORS: AMOUNTS|||FALLING DUE WITHIN ONE YEAR||||
||||||2020|2019|
||||||S|5|
|Trade creditors|||||1,769|1,706|
|Socialsecurity
and other|||taxes|||4,811|
|Other creditors|||||1,303|1,303|
|Accruals|and deferred|income|||59,876|50,502|
||||||62,948|58,322|
|Deferred|subscription|income:|||||
||||||2020|2019|
||||||S|S|
|Deferred|subscription|income brought forward|||500|196|
|Released|in year||||(200)|(196)|
|Received|in advance|during the year|||340|500|
|Deferred|subscription|income carried forward|||640|500|
##
##
|MOVEMENT|IN|FUN|DS|||||||
|---|---|---|---|---|---|---|---|---|---|
||||||||Net|Transfers||
||||||||movement|between|At.|
|||||||At 1/1/20|in funds|funds|31/12/20|
|||||||S|||5|
|Unrestricted|funds|||||||||
|General fund||||||14,420,265|951,148|(152,020)|15,219,393|
|Restricted funds||||||||||
|IFD Genera|I||||||(66,359)|66,359||
|IFD RDTC|||||||(96,771)|96,771||
|IFD Community||Skin|Health Journal||||(14,315)|14,315||
|IFD Persons|with Albinism|||||48|(20,000)|19,952||
|IFD IACS|||||||(10,000)|10,000||
|ILDS Global|Psoriasis||Atlas|||285,193|(103,250)||181,943|
|||||||285,241|(310,695)|207,397|181,943|
|Endowment|funds|||||||||
|IFD (Moshi|RDTC) Endowment|||Fund||1,146,509|58,108|(55,377)|1,149,240|
|TOTALFUNDS||||||15,852,015|698,561||16,550,576|
|Net movement||in funds, included|||in the above are as follows:|||||
|||||||Incoming|Resources|Gains and|Movement|
|||||||resources|expended|losses|in funds|
|Unrestricted|funds|||||||||
|General fund||||||230,328|195,561|525,259|951,148|
|Restricted funds||||||||||
|IFD General||||||22,904|(89,263)||(66,359)|
|IFD RDTC||||||128,832|(225,603)||(96,771)|
|IFD Community||Skin|Health Journal|||1,192|(15,507)||(14,315)|
|IFD Persons|with Albinism||||||(20,000)||(20,000)|
|IFD IACS|||||||(10,000)||(10,000)|
|ILDSGlobalPsoriasis|||Atlas|||142,489|(245,739)||(103,250)|
|||||||295,417|(606,112)||(310,695)|
|Endowment|funds|||||||||
|IFD (Moshi|RDTC) Endowment|||Fund||22,464|(6,841)|42,485|58,108|
|TOTALFUNDS||||||548,209|(417,392)|567,744|698,561|
##
|17.|MOVEMENT|IN|FUNDS - continued|FUNDS - continued||||||
|---|---|---|---|---|---|---|---|---|---|
||Camparatives|for movement||in funds||||||
||||||||Net|Transfers||
||||||||movement|between|At|
|||||||At 1/1/19|in funds|funds|31/12/19|
|||||||$|||$|
||Unrestricted|funds||||||||
||General fund||||4,777,216||9,822,454|(179,405)|14,420,265|
||Restricted funds|||||||||
||IFD General||||||(64,452)|64,452||
||IFD RDTC|||||32,387|(88,502)|56,115||
||IFD Community||Skin Health Journal||||(37,382)|37,382||
||IFD Persons|with|Albinism||||48||48|
||IF D IACS|||||(9,950)|(11,506)|21,456||
||ILDS Global Psoriasis Atlas|||||62,397|222,796||285,193|
|||||||84,834|21,002|179,405|285,241|
||Endowment|funds||||||||
||IFD (Moshi RDTC) Endowment|||Fund|1,064,269||82,240||1,146,509|
||TOTALFUNDS||||5,926,319||9,925,696|-|15,852,015|
||Comparative|net movement||in funds,|included|in the abave are as follows:||||
|||||||Incoming|Resources|Gains and|Movement|
|||||||resources|expended|losses|in funds|
||||||||$|$||
||Unrestricted|funds||||||||
||General fund||||10,012,293||(683,861)|494,022|9,822,454|
||Restricted funds|||||||||
||IFD General||||||(64,452)||(64,452)|
||IFD RDTC|||||115,836|(204,338)||(88,502)|
||IFD Community||Skin Health Journal|||1,474|(38,856)||(37,382)|
||IFD Persons|with|Albinism|||48|||48|
||IFD IACS||||||(11,506)||(11,506)|
||ILDS Global Psoriasis Atlas|||||315,123|(92,327)||222,796|
|||||||432,481|(411,479)||21,002|
||Endowment|funds||||||||
||IFD (Moshi RDTC) Endowment|||Fund||36,482|(5,702)|51,460|82,240|
||TOTAL FUNDS||||10,481,256||(1,101,042)|545,482|9,925,696|
##
##
##
##
##
##